# CINVANTI
> **NDA209296** · New Drug Application · Sponsor: HERON THERAPS INC · Approved 2017-11-09
## Drug
- **FDA Application Number:** NDA209296
- **Application type:** New Drug Application
- **Brand name:** CINVANTI
- **Generic name:** APREPITANT
- **Active ingredients:** APREPITANT
- **Dosage form:** EMULSION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** HERON THERAPS INC
- **Manufacturer:** Heron Therapeutics, Inc.
- **First approval:** 2017-11-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209296)
---
*AI Analytics · CC0 1.0*